<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39308913</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-9439</ISSN><JournalIssue CitedMedium="Internet"><Volume>112</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the Medical Library Association : JMLA</Title><ISOAbbreviation>J Med Libr Assoc</ISOAbbreviation></Journal><ArticleTitle>Evaluating the discoverability of supporting research materials in ClinicalTrials.gov for US federally funded COVID-19 clinical studies.</ArticleTitle><Pagination><StartPage>250</StartPage><EndPage>260</EndPage><MedlinePgn>250-260</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5195/jmla.2024.1799</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">The objective of this study was to evaluate the discoverability of supporting research materials, including supporting documents, individual participant data (IPD), and associated publications, in US federally funded COVID-19 clinical study records in ClinicalTrials.gov (CTG).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Study registration records were evaluated for (1) links to supporting documents, including protocols, informed consent forms, and statistical analysis plans; (2) information on how unaffiliated researchers may access IPD and, when applicable, the linking of the IPD record back to the CTG record; and (3) links to associated publications and, when applicable, the linking of the publication record back to the CTG record.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">206 CTG study records were included in the analysis. Few records shared supporting documents, with only 4% of records sharing all 3 document types. 27% of records indicated they intended to share IPD, with 45% of these providing sufficient information to request access to the IPD. Only 1 dataset record was located, which linked back to its corresponding CTG record. The majority of CTG records did not have links to publications (61%), and only 21% linked out to at least 1 results publication. All publication records linked back to their corresponding CTG records.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">With only 4% of records sharing all supporting document types, 12% sufficient information to access IPD, and 21% results publications, improvements can be made to the discoverability of research materials in federally funded, COVID-19 CTG records. Sharing these materials on CTG can increase their discoverability, therefore increasing the validity, transparency, and reusability of clinical research.</AbstractText><CopyrightInformation>Copyright © 2024 Paije Wilson, Vojtech Huser.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Paije</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0799-4776</Identifier><AffiliationInfo><Affiliation>paije.wilson@wisc.edu, Health Sciences Librarian, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huser</LastName><ForeName>Vojtech</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-0709-6573</Identifier><AffiliationInfo><Affiliation>v.huser@gwu.edu, Adjunct Professor of Clinical Research and Leadership, The George Washington University School of Medicine &amp; Health Sciences, Washington, D.C.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Libr Assoc</MedlineTA><NlmUniqueID>101132728</NlmUniqueID><ISSNLinking>1536-5050</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005380" MajorTopicYN="N">Financing, Government</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="N">Information Dissemination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Clinical studies</Keyword><Keyword MajorTopicYN="N">Data sharing</Keyword><Keyword MajorTopicYN="N">clinicaltrials.gov</Keyword><Keyword MajorTopicYN="N">discoverability</Keyword><Keyword MajorTopicYN="N">research transparency</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>5</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39308913</ArticleId><ArticleId IdType="pmc">PMC11412123</ArticleId><ArticleId IdType="doi">10.5195/jmla.2024.1799</ArticleId><ArticleId IdType="pii">jmla.2024.1799</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>FDA guidance on conduct of clinical trials of medical products during the COVID-19 public health emergency: guidance for industry, investigators, and institutional review boards: US Food and Drug Administration; 2020.  [updated March 2020, cited 2 Feb 2023]. Available from: https://www.fda.gov/media/136238/download.</Citation></Reference><Reference><Citation>Ewers M, Ioannidis JPA, Plesnila N.. Access to data from clinical trials in the COVID-19 crisis: open, flexible, and time-sensitive. J Clin Epidemiol. 2021. Feb;130:143–6. DOI: 10.1016/j.jclinepi.2020.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2020.10.008</ArticleId><ArticleId IdType="pmc">PMC7554475</ArticleId><ArticleId IdType="pubmed">33068714</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell EJ, Ahmed K, Breeman S, Cotton S, Constable L, Ferry G, et al.. It is unprecedented: trial management during the COVID-19 pandemic and beyond. Trials. 2020. Sep 11;21(1):1–7. DOI: 10.1186/s13063-020-04711-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-020-04711-6</ArticleId><ArticleId IdType="pmc">PMC7484918</ArticleId><ArticleId IdType="pubmed">32917258</ArticleId></ArticleIdList></Reference><Reference><Citation>Studies found for: COVID-19: ClinicalTrials.gov; [cited 2 Feb 2023]. Available from: https://clinicaltrials.gov/ct2/results?cond=COVID-19.</Citation></Reference><Reference><Citation>Rodgers F, Pepperrell T, Keestra S, Pilkington V.. Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs. Trials. 2021. Jan 15;22(1):1–10. DOI: 10.1186/s13063-021-05024-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05024-y</ArticleId><ArticleId IdType="pmc">PMC7809643</ArticleId><ArticleId IdType="pubmed">33451350</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapp P, Esmail L, Ghosn L, Ravaud P, Boutron I.. Transparency and reporting characteristics of COVID-19 randomized controlled trials. BMC Med. 2022. Sep 26;20(1):1–14. DOI: 10.1186/s13063-021-05024-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05024-y</ArticleId><ArticleId IdType="pmc">PMC9510360</ArticleId><ArticleId IdType="pubmed">36154932</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira da Silva JA, Bornemann-Cimenti H, Tsigaris P.. Optimizing peer review to minimize the risk of retracting COVID-19-related literature. Med Health Care Philos. 2021. Mar;24(1):21–6. DOI: 10.1007/s11019-020-09990-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11019-020-09990-z</ArticleId><ArticleId IdType="pmc">PMC7678589</ArticleId><ArticleId IdType="pubmed">33216274</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, von Isenburg M, Levenstein M, Neumann S, Wood J, Sim I.. COVID-19 trials: declarations of data sharing intentions at trial registration and at publication. Trials. 2021. Feb 18;22(1):1–5. DOI: 10.1186/s13063-021-05104-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05104-z</ArticleId><ArticleId IdType="pmc">PMC7891481</ArticleId><ArticleId IdType="pubmed">33602275</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson K, Sim I, von Isenburg M, Levenstein M, Rockhold F, Neumann S, et al.. COVID-19 interventional trials: analysis of data sharing intentions during a time of pandemic. Contemp Clin Trials. 2022. Apr;115:1–5. DOI: 10.1016/j.cct.2022.106709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2022.106709</ArticleId><ArticleId IdType="pmc">PMC8847110</ArticleId><ArticleId IdType="pubmed">35182738</ArticleId></ArticleIdList></Reference><Reference><Citation>Naudet F, Siebert M, Pellen C, Gaba J, Axfors C, Cristea I, et al.. Medical journal requirements for clinical trial data sharing: ripe for improvement. PLoS Med. 2021. Oct;18(10):1–8. DOI: 10.1371/journal.pmed.1003844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003844</ArticleId><ArticleId IdType="pmc">PMC8575305</ArticleId><ArticleId IdType="pubmed">34695113</ArticleId></ArticleIdList></Reference><Reference><Citation>Mello MM, Lieou V, Goodman SN.. Clinical trial participants' views of the risks and benefits of data sharing. N Engl J Med. 2018. Jun 7;378(23):2202–11. DOI: 10.1056/NEJMsa1713258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa1713258</ArticleId><ArticleId IdType="pmc">PMC6057615</ArticleId><ArticleId IdType="pubmed">29874542</ArticleId></ArticleIdList></Reference><Reference><Citation>Final NIH policy for data management and sharing NOT-OD-21-013: National Institutes of Health; 2020.  [cited 2 Feb 2023]. Available from: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-013.html.</Citation></Reference><Reference><Citation>Chen R, Desai NR, Ross JS, Zhang W, Chau KH, Wayda B, et al.. Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers. Bmj. 2016. Feb 17;352:i637. DOI: 10.1136/bmj.i637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i637</ArticleId><ArticleId IdType="pmc">PMC4768882</ArticleId><ArticleId IdType="pubmed">26888209</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones CW, Adams AC, Murphy E, King RP, Saracco B, Stesis KR, et al.. Delays in reporting and publishing trial results during pandemics: cross sectional analysis of 2009 H1N1, 2014 Ebola, and 2016 Zika clinical trials. BMC Med Res Methodol. 2021. Jun 8;21(1):1–10. DOI: 10.1186/s12874-021-01324-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-021-01324-8</ArticleId><ArticleId IdType="pmc">PMC8185489</ArticleId><ArticleId IdType="pubmed">34103009</ArticleId></ArticleIdList></Reference><Reference><Citation>Naudet F, Sakarovitch C, Janiaud P, Cristea I, Fanelli D, Moher D, et al.. Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and PLOS Medicine. Bmj. 2018. Feb 13;360:1–11. DOI: 10.1136/bmj.k400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k400</ArticleId><ArticleId IdType="pmc">PMC5809812</ArticleId><ArticleId IdType="pubmed">29440066</ArticleId></ArticleIdList></Reference><Reference><Citation>Taichman DB, Sahni P, Pinborg A, Peiperl L, Laine C, James A, et al.. Data sharing statements for clinical trials. Bmj. 2017. Jun 5;357:1–3. DOI: 10.1136/bmj.j2372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j2372</ArticleId><ArticleId IdType="pmc">PMC5455164</ArticleId><ArticleId IdType="pubmed">28584025</ArticleId></ArticleIdList></Reference><Reference><Citation>NIH policy on the dissemination of NIH-funded clinical trial information NOT-OD-16-149: National Institutes of Health Office of Science Policy; 2016.  [cited 2 Feb 2023]. Available from: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-149.html.</Citation></Reference><Reference><Citation>42 CFR Part II: clinical trials registration and results information submission; Final Rule: Department of Health and Human Services; 2016. NIH–2011–0003 [cited 2 Feb 2023]. Available from: https://www.ecfr.gov/current/title-42/chapter-I/subchapter-A/part-11.</Citation></Reference><Reference><Citation>Public health emergency COVID-19 initiative: National Library of Medicine; 2022.  [cited 2 Feb 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/about/covid-19/.</Citation></Reference><Reference><Citation>Sharing research data and findings relevant to the novel coronavirus (COVID-19) outbreak: Wellcome Trust; 2020.  [cited 2 Feb 2023]. Available from: https://wellcome.org/press-release/sharing-research-data-and-findings-relevant-novel-coronavirus-ncov-outbreak.</Citation></Reference><Reference><Citation>A letter to members of the scholarly publishing community: National Science and Technology Advisors; 2020.  [cited 2 Feb 2023]. Available from: https://www.imagwiki.nibib.nih.gov/sites/default/files/COVID19%20Open%20Access%20Letter%20from%20CSAs.Equivalents_0.pdf.</Citation></Reference><Reference><Citation>Nelson A.. 
Memorandum: ensuring free, immediate, and equitable access to federally funded research: Office of Science and Technology Policy; 2022.  [cited 2 Feb 2023]. Available from: https://www.whitehouse.gov/wp-content/uploads/2022/08/08-2022-OSTP-Public-Access-Memo.pdf.</Citation></Reference><Reference><Citation>ClinicalTrials.gov background: ClinicalTrials.gov; 2021.  [cited 2 Feb 2023]. Available from: https://clinicaltrials.gov/ct2/about-site/background#WhatInformationCanIFind.</Citation></Reference><Reference><Citation>ClinicalTrials.gov protocol registration data element definitions for interventional and observational studies: ClinicalTrials.gov; 2020.  [cited 2 Feb 2023]. Available from: https://prsinfo.clinicaltrials.gov/definitions.html.</Citation></Reference><Reference><Citation>Mayer CS, Huser V.. regCOVID: tracking publications of registered COVID-19 studies. BMC Med Res Methodol. 2022. Aug 10;22(1):1–10. DOI: 10.1186/s12874-022-01703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-022-01703-9</ArticleId><ArticleId IdType="pmc">PMC9364859</ArticleId><ArticleId IdType="pubmed">35948881</ArticleId></ArticleIdList></Reference><Reference><Citation>Glossary of common site terms: ClinicalTrials.gov; 2021.  [cited 2 Feb 2023]. Available from: https://clinicaltrials.gov/ct2/about-studies/glossary.</Citation></Reference><Reference><Citation>Salholz-Hillel M, Strech D, Carlisle BG.. Results publications are inadequately linked to trial registrations: an automated pipeline and evaluation of German university medical centers. Clin Trials. 2022. Apr 1:337-46. DOI: 10.1177/17407745221087456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17407745221087456</ArticleId><ArticleId IdType="pmc">PMC9203676</ArticleId><ArticleId IdType="pubmed">35362331</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashir R, Bourgeois FT, Dunn AG.. A systematic review of the processes used to link clinical trial registrations to their published results. Syst Rev. 2017. Jul 3;6(1):1–17. DOI: 10.1186/s13643-017-0518-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-017-0518-3</ArticleId><ArticleId IdType="pmc">PMC5494826</ArticleId><ArticleId IdType="pubmed">28669351</ArticleId></ArticleIdList></Reference><Reference><Citation>Huser V, Cimino JJ.. Precision and negative predictive value of links between ClinicalTrials.gov and PubMed. AMIA Annu Symp Proc. 2012;2012:400–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540528</ArticleId><ArticleId IdType="pubmed">23304310</ArticleId></ArticleIdList></Reference><Reference><Citation>How to find results of studies: ClinicalTrials.gov; 2021.  [cited 2 Feb 2023]. Available from: https://clinicaltrials.gov/ct2/help/how-find/find-study-results.</Citation></Reference><Reference><Citation>Email from NLM Support Team. Email message to: Paije Wilson. National Library of Medicine Help Desk; 2023</Citation></Reference><Reference><Citation>MEDLINE/PubMed data element (field) descriptions: National Library Of Medicine; 2019.  [cited 2 Feb 2023]. Available from: https://www.nlm.nih.gov/bsd/mms/medlineelements.html#si.</Citation></Reference><Reference><Citation>PubMed user guide: National Library of Medicine; 2023.  [cited 2 Feb 2023]. Available from: https://pubmed.ncbi.nlm.nih.gov/help/#tw.</Citation></Reference><Reference><Citation>Ohmann C, Moher D, Siebert M, Motschall E, Naudet F.. Status, use and impact of sharing individual participant data from clinical trials: a scoping review. BMJ Open. 2021. Aug 18;11(8):1–21. DOI: 10.1136/bmjopen-2021-049228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-049228</ArticleId><ArticleId IdType="pmc">PMC8375721</ArticleId><ArticleId IdType="pubmed">34408052</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaba JF, Siebert M, Dupuy A, Moher D, Naudet F.. Funders' data-sharing policies in therapeutic research: a survey of commercial and non-commercial funders. PLoS One. 2020;15(8):1–14. DOI: 10.1371/journal.pone.0237464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0237464</ArticleId><ArticleId IdType="pmc">PMC7446799</ArticleId><ArticleId IdType="pubmed">32817724</ArticleId></ArticleIdList></Reference><Reference><Citation>Taichman DB, Sahni P, Pinborg A, Peiperl L, Laine C, James A, et al.. Data sharing statements for clinical trials: a requirement of the International Committee of Medical Journal Editors. PLoS Med. 2017. Jun;14(6):1–3. DOI: 10.1371/journal.pmed.1002315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002315</ArticleId><ArticleId IdType="pmc">PMC5459581</ArticleId><ArticleId IdType="pubmed">28582414</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergeris A, Tse T, Zarin DA.. 
Trialists' intent to share individual participant data as disclosed at ClinicalTrials.gov. Jama. 2018. 
Jan
23;319(4):406–8. DOI: 10.1001/jama.2017.20581. Available from: https://jamanetwork.com/journals/jama/articlepdf/2670243/jama_bergeris_2018_ld_170053.pdf.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.20581</ArticleId><ArticleId IdType="pmc">PMC5806046</ArticleId><ArticleId IdType="pubmed">29362784</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson C.. Many researchers say they'll share data - but don't. Nature. 2022. Jun;606(7916):853. DOI: 10.1038/d41586-022-01692-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-01692-1</ArticleId><ArticleId IdType="pubmed">35725829</ArticleId></ArticleIdList></Reference><Reference><Citation>Piwowar HA, Vision TJ.. Data reuse and the open data citation advantage. PeerJ. 2013;1:1–25. DOI: 10.7717/peerj.175.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.175</ArticleId><ArticleId IdType="pmc">PMC3792178</ArticleId><ArticleId IdType="pubmed">24109559</ArticleId></ArticleIdList></Reference><Reference><Citation>Colavizza G, Hrynaszkiewicz I, Staden I, Whitaker K, McGillivray B.. The citation advantage of linking publications to research data. PLoS One. 2020;15(4):1–18. DOI: 10.1371/journal.pone.0230416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0230416</ArticleId><ArticleId IdType="pmc">PMC7176083</ArticleId><ArticleId IdType="pubmed">32320428</ArticleId></ArticleIdList></Reference><Reference><Citation>Data Confidentiality: ICPSR's Approach to Confidentiality; 2023.  [cited 7 Oct 2023]. Available from: https://www.icpsr.umich.edu/web/pages/datamanagement/confidentiality/index.html.</Citation></Reference><Reference><Citation>Clinical trials: International Committee of Medical Journal Editors; 2023.  [cited 2 Feb 2023]. Available from: https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>